ClinicalTrialsFinder

Epidermolysis Bullosa Dystrophica, Recessive Clinical Trials in Toronto, Ontario

1 recruitingToronto, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

Recessive dystrophic epidermolysis bullosaEpidermolysis Bullosa Dystrophica, RecessiveRDEB
CHU de Quebec-Universite Laval9 enrolled1 locationNCT07193134